Indeed, molecular data previously generated showed that EAAT1 and EAAT2 mRNA levels are largely modified in ALS patients and, moreover, these modifications were associated with the increased oxidative stress present in the affected cases (24,25). The gene discussed is SLC1A2; the disease is amyotrophic lateral sclerosis.